Agilent Technologies Collaborates with UC San Diego Researchers Seeking New Leukaemia Identification Methods

13-Jul-2009 - USA

The Agilent Foundation, supported by Agilent Technologies Inc., announced a collaboration to support leukaemia research at the Ideker Laboratory at the University of California, San Diego. The lab is investigating the relationships between genetic variations and proteins in the search for better methods of analyzing the disease. The collaboration includes scientific and financial support.

“Professor Trey Ideker’s team will explore a promising new approach for recognizing the mechanism that triggers leukaemia using multiple scientific disciplines. This could produce a powerful new tool for detection and treatment,” said Allan Kuchinsky, the Agilent Laboratories scientist sponsoring the Ideker Lab for the Agilent Foundation support.

“This gift from the Agilent Foundation will allow us to develop a system for analyzing proteomics data to map pathways, and for finding protein-network biomarkers of cancer,” Ideker said.

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances